BFRA - バイオフロンテラ (Biofrontera AG) バイオフロンテラ

 BFRAのチャート


 BFRAの企業情報

symbol BFRA
会社名 Biofrontera AG (バイオフロンテラ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   バイオフロンテラはドイツのバイオ医薬品企業。主に、日光の紫外線による皮膚病および皮膚疾患の治療薬の開発・商品化に従事する。皮膚がんにつながる皮膚病変である皮膚線維化・角化症の治療や、欧州連合における基底細胞がんの治療に焦点をあてた治療薬「Ameluz」、「Belixos」、「Rhodoled」が主要製品である。本社所在地はレバ―ク―ゼン。   
本社所在地 Hemmelrather Weg 201 Leverkusen D-51377 DEU
代表者氏名
代表者役職名
電話番号
設立年月日 1997年
市場名 NASDAQ Small Cap
ipoyear 2018年
従業員数 119人
url www.biofrontera.com
nasdaq_url https://www.nasdaq.com/symbol/bfra
adr_tso 934456
EBITDA EBITDA ー
終値(lastsale) 13.2296
時価総額(marketcap) 12362479.0976
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 BFRAのテクニカル分析


 BFRAのニュース

   Biofrontera Stock Plunges After Announcing Nasdaq Delisting By Investing.com  2022/02/14 20:28:00 Investing.com
Biofrontera Stock Plunges After Announcing Nasdaq Delisting
   Biofrontera to delist American Depositary Shares to cut costs (NASDAQ:BFRA)  2022/02/14 19:29:12 Seeking Alpha
Biofrontera <> announced that the company decided to delist its American Depositary Shares ((ADS)) from the Nasdaq Capital Market
   5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More  2022/02/07 15:42:18 Benzinga
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy back the shares they initially borrowed at a higher price. A squeeze can occur when short sellers are forced into buying to cover their position, which can cause shares to go much higher on many occasions. Fintel Data: Data from Fintel , which requires a subscription, provides a look at several of the top shorted stocks and data on how likely a short squeeze is to occur. Heres a look at Fintels top five short squeeze candidates for the week of Feb. 7. Vinco Ventures: Topping the list this week is Full story available on Benzinga.com
   Why Are Biofrontera Shares Rising Today?  2022/02/01 19:31:10 Benzinga
Biofrontera Inc (NASDAQ: BFRI ) has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-RhodoLED lamp in the U.S. To date, 70% of the planned 186 patients have been enrolled in the study. Patient recruitment for this study has been ongoing since 2018, with the Full story available on Benzinga.com
   Biofrontera spikes after recruitment update on late-stage trial for skin cancer  2022/02/01 15:35:30 Seeking Alpha
Biofrontera <> is trading sharply higher after announcing that the company enrolled 70% of patients in its Phase 3 study for Ameluz photodynamic therapy in superficial basal…
   Biofrontera Stock Plunges After Announcing Nasdaq Delisting By Investing.com  2022/02/14 20:28:00 Investing.com
Biofrontera Stock Plunges After Announcing Nasdaq Delisting
   Biofrontera to delist American Depositary Shares to cut costs (NASDAQ:BFRA)  2022/02/14 19:29:12 Seeking Alpha
Biofrontera <> announced that the company decided to delist its American Depositary Shares ((ADS)) from the Nasdaq Capital Market
   5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More  2022/02/07 15:42:18 Benzinga
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy back the shares they initially borrowed at a higher price. A squeeze can occur when short sellers are forced into buying to cover their position, which can cause shares to go much higher on many occasions. Fintel Data: Data from Fintel , which requires a subscription, provides a look at several of the top shorted stocks and data on how likely a short squeeze is to occur. Heres a look at Fintels top five short squeeze candidates for the week of Feb. 7. Vinco Ventures: Topping the list this week is Full story available on Benzinga.com
   Why Are Biofrontera Shares Rising Today?  2022/02/01 19:31:10 Benzinga
Biofrontera Inc (NASDAQ: BFRI ) has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with BF-RhodoLED lamp in the U.S. To date, 70% of the planned 186 patients have been enrolled in the study. Patient recruitment for this study has been ongoing since 2018, with the Full story available on Benzinga.com
   Biofrontera spikes after recruitment update on late-stage trial for skin cancer  2022/02/01 15:35:30 Seeking Alpha
Biofrontera <> is trading sharply higher after announcing that the company enrolled 70% of patients in its Phase 3 study for Ameluz photodynamic therapy in superficial basal…
   Biofrontera Raises $8.9M Via Equity Offering  2021/02/24 07:17:00 Benzinga
Biofrontera AG (NASDAQ: BFRA) priced an underwritten public offering of around 1.3 million ADS at $6.68 per ADS, raising gross proceeds …
   Impact of Covid-19 On Dermatology Treatment Devices Market 2021 | Enormous Growth With Recent Trends & Demand By Top Vendors Cutera Inc., Bausch Health Companies Inc., Sciton Inc., Lumenis, Alma Lasers, Cynosure, Candela Corporation, Biofrontera Ag, Avita  2021/02/11 21:34:59 OpenPR
The "Global Dermatology Treatment Devices Market Analysis to 2027" is a specialized and in-depth study of the Dermatology Treatment Devices market with a focus on the global market trend. The report aims to provide an overview of the global Dermatology
   Cologne Higher Regional Court grants approval of capital increase  2021/01/07 16:45:00 GlobeNewswire
Leverkusen, Germany, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international…
   Actinic Keratosis Drugs Market Research Report (2020-2026): Key Trends and Opportunities |GALDERMA, LEO Pharma, Valeant, Biofrontera  2020/12/15 07:09:58 OpenPR
The global Actinic Keratosis Drugs market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and
   Dermatology Treatment Devices Market Is Expected To Reach US$ 8,800.07 Million In By 2027 With Cutera Inc.; Bausch Health Companies Inc.; Sciton, Inc.; Lumenis; Alma Lasers; Cynosure, Candela Corporation; Biofrontera Ag; Avita Medical; and PhotoMedex  2020/11/25 13:37:14 OpenPR
The proposed Dermatology Treatment Devices Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes

 関連キーワード  (― 米国株 バイオフロンテラ BFRA Biofrontera AG)

 twitter  (公式ツイッターやCEOツイッターなど)